The challenges to mental health care posed by the coronavirus pandemic are vast. In addition to significantly increased reports of anxiety and depression, and a sharp decrease in needed medical care, clinicians are seeing worsening mental health outcomes, increased substance use, and elevated suicidal ideation.¹
According to a recent survey, 41% of adults reported symptoms of anxiety and/or depressive disorder in January 2021 (a significant increase from the 11% reported during the same period in 2019) and 36% reported delaying or not getting the medical care they need because of the pandemic.² Additionally, 13% of adults reported new or increased substance use due to coronavirus-related stress, and 11% reported thoughts of suicide in the past 30 days.¹
Watch this video to learn more about Cordant’s findings in our short video, Unlocking the Data: Cordant’s Mental Health Adherence Testing Identifies What Is Not Seen Today.
An analysis of drug test results from mental health patients in Cordant’s program where medications were reported as prescribed revealed surprising insights:
Analysis of 17,720 samples from mental health patients in Cordant’s program where a medication was reported as prescribed with the test order; Jan 2018–Sept 2019
Medication non-adherence accounts for 30–50% of treatment failures.
Studies show that patients often overstate adherence because they fear disappointing their provider and that clinicians generally overestimate their own ability to identify and quantify non-adherence among their patients, highlighting the importance of objective and validated approaches to measurement, such as testing.